Cape Investment Advisory’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-26
Closed -$412 – 1313
2025
Q3
$412 Hold
26
– – ﹤0.01% 787
2025
Q2
$298 Hold
26
– – ﹤0.01% 1099
2025
Q1
$352 Hold
26
– – ﹤0.01% 1033
2024
Q4
$439 Buy
+26
New +$506 ﹤0.01% 1021
2024
Q2
– Sell
-107
Closed -$2.8K – 938
2024
Q1
$2.8K Buy
107
+1
+0.9% +$28 ﹤0.01% 731
2023
Q4
$3.33K Buy
106
+1
+1% +$27 ﹤0.01% 844
2023
Q3
$2.94K Buy
105
+1
+1% +$34 ﹤0.01% 752
2023
Q2
$3.84K Buy
104
+1
+1% +$31 ﹤0.01% 697
2023
Q1
$3.09K Buy
+103
New +$3.39K ﹤0.01% 764

Other funds holding CC

Cape Investment Advisory's CC Position: Q4 2025 in Review

Cape Investment Advisory sold out of Chemours (CC) in Q4 2025, closing a stake of 26 shares — an estimated $412 sold.

Cape Investment Advisory first reported a position in CC in Q1 2023 and held it in 9 quarters. The position peaked at $3.84K in Q2 2023. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Cape Investment Advisory reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Cape Investment Advisory sold 26 Chemours shares in Q4 2025, an estimated $412.
  • Cape Investment Advisory first reported a position in Chemours in Q1 2023 and held it in 9 quarters.
  • Cape Investment Advisory's Chemours position peaked at $3.84K in Q2 2023.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Cape Investment Advisory's 13F filing for Q4 2025, filed 17 Feb 2026.